India to launch indigenous vaccine against cervical cancer today | Latest News India - Hindustan Times
close_game
close_game

India to launch indigenous vaccine against cervical cancer today

ByPress Trust of India, New Delhi
Sep 01, 2022 04:42 AM IST

India’s first indigenously developed quadrivalent Human Papilloma Virus (HPV) vaccine for the prevention of cervical cancer will be launched here on Thursday, officials said on Wednesday.

India’s first indigenously developed quadrivalent Human Papilloma Virus (HPV) vaccine for the prevention of cervical cancer will be launched here on Thursday, officials said on Wednesday.

India’s first indigenously developed quadrivalent Human Papilloma Virus (HPV) vaccine for the prevention of cervical cancer will be launched today.
India’s first indigenously developed quadrivalent Human Papilloma Virus (HPV) vaccine for the prevention of cervical cancer will be launched today.

The Drugs Controller General of India (DCGI) had last month granted market authorisation to Serum Institute of India (SII) to manufacture an indigenously-developed vaccine against cervical cancer.

HT launches Crick-it, a one stop destination to catch Cricket, anytime, anywhere. Explore now!

Also read: Only 12% in 18-59 age group have taken Covid vaccine booster dose: Data

Union Minister of Science and Technology Jitendra Singh will launch the vaccine at IIC Delhi. SII CEO Adar Poonawalla will be present at the event, the officials said.

According to the officials, the qHPV vaccine CERVAVAC has demonstrated robust antibody response that is nearly 1,000 times higher than the baseline against all targeted HPV types and in all dose and age groups.

Cervical cancer in India ranks as the second most frequent cancer among women between 15 and 44 years of age.

Also read: Ahead of Ganpati festival, only two mandals seek vaccination drive

The DCGI’s approval had come following recommendation by the Subject Expert Committee (SEC) on COVID-19 of the CDSCO on June 15 after Prakash Kumar Singh, director (government and regulatory affairs) at Serum Institute, had applied to the DCGI seeking market authorisation of qHPV after the phase second and third clinical trial was completed with support of the Department of Biotechnology under the Ministry of Science and Technology to ensure its early availability.

Discover the complete story of India's general elections on our exclusive Elections Product! Access all the content absolutely free on the HT App. Download now!

Get Current Updates on India News, Ram Navami Live Updates , Lok Sabha Election 2024 live, Elections 2024, Election 2024 Date along with Latest News and Top Headlines from India and around the world.
SHARE THIS ARTICLE ON
Share this article
SHARE
Story Saved
Live Score
OPEN APP
Saved Articles
Following
My Reads
Sign out
New Delhi 0C
Thursday, April 18, 2024
Start 14 Days Free Trial Subscribe Now
Follow Us On